CANCER RESEARCH INSTITUTE INC

EIN: 131837442 501(c)(3) Medical Research

NEW YORK, NY

Total Revenue
$23,964,638
Total Expenses
$32,820,896
Total Assets
$133,734,670
Net Assets
$66,830,635
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
1953
Legal Domicile
NY
Principal Officer
ALICIA ZHOU PHD
Phone
2126887515
Tax Period
2023-07-01 to 2024-06-30

CANCER RESEARCH INSTITUTE INC, founded in 1953, is a mid-sized nonprofit in the Medical Research sector that reported $24.0M in total revenue in fiscal year 2023. Revenue fell 26% from the prior year — a significant decline worth monitoring. Expenses of $32.8M exceeded revenue, resulting in a 37% operating deficit.

Mission

SEE ON SCHEDULE OTHE CANCER RESEARCH INSTITUTE'S MISSION IS TO SAVE MORE LIVES BYFUELING THE DISCOVERY AND DEVELOPMENT OF POWERFUL IMMUNOTHERAPIES FORALL TYPES OF CANCER. TO ACCOMPLISH THIS, CRI FUNDS LABORATORY,TRANSLATIONAL, AND CLINICAL RESEARCH.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $20,143,304
Program Service Revenue $0
Investment Income $3,783,274
Other Revenue $38,060
TOTAL REVENUE $23,964,638

Expense Breakdown

Grants Paid $22,471,018
Salaries & Benefits $5,354,714
Fundraising Expenses $3,445,611
Program Expenses $26,628,724
Other Expenses $4,995,164
TOTAL EXPENSES $32,820,896

Year-over-Year Comparison

2023 2022 Change
Revenue $23,964,638 $32,295,259 -0.3%
Expenses $32,820,896 $38,552,663 -0.1%
Net Income $-8,856,258 $-6,257,404 +0.4%
Key Indicators
✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✓ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
33
Independent Members
33
Employees
32
Volunteers
250

Governance Policies

✓ Conflict of Interest Policy
✓ Whistleblower Policy
✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
10
$1,049,619
Total Directors
36
$0
Key Employees
5
$1,583,701
Highest Compensated
5
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
PAUL C SHIVERICK CHAIRMEN 5.00
Officer Director
$0 $0 $0
ANDREW K TSAI CHAIRMEN 5.00
Officer Director
$0 $0 $0
DONALD J GOGEL VICE CHAIRMEN 3.00
Officer Director
$0 $0 $0
EDGAR R BERNER VICE CHAIRMEN 3.00
Officer Director
$0 $0 $0
GEOFFREY O COLEY TREASURER 3.00
Officer Director
$0 $0 $0
THOMAS G MENDELL SECRETARY 1.00
Officer Director
$0 $0 $0
TONY ALVAREZ II TRUSTEE 0.50
Director
$0 $0 $0
YACOV ARNOPOLIN TRUSTEE 4.00
Director
$0 $0 $0
PETER L BLOOM TRUSTEE 4.00
Director
$0 $0 $0
BRIAN J BRILLE TRUSTEE 1.00
Director
$0 $0 $0
MICHAEL R CRAWFORD TRUSTEE (THRU 4/2024) 1.00
Director
$0 $0 $0
W ROBERT DAHL TRUSTEE 1.00
Director
$0 $0 $0
MAXWELL DAVID TRUSTEE 0.25
Director
$0 $0 $0
GLENN J DESIMONE TRUSTEE (THRU 7/2023) 1.00
Director
$0 $0 $0
SEAN P FAHEY TRUSTEE 1.00
Director
$0 $0 $0
WILLIAM S GOLDBERG TRUSTEE 0.25
Director
$0 $0 $0
OLIVER R GRACE JR TRUSTEE 1.00
Director
$0 $0 $0
SANDRA COUDERT GRAHAM TRUSTEE 0.50
Director
$0 $0 $0
MICHAEL M KELLEN TRUSTEE 1.00
Director
$0 $0 $0
SARAH KIM TRUSTEE 3.00
Director
$0 $0 $0
FERN LAZAR TRUSTEE 3.00
Director
$0 $0 $0
ALEXANDER P LYNCH TRUSTEE (THRU 7/2023) 1.00
Director
$0 $0 $0
SANDRA OZOLA TRUSTEE 0.25
Director
$0 $0 $0
MICHAEL J PETRICK TRUSTEE 0.50
Director
$0 $0 $0
LIEF D ROSENBLATT TRUSTEE 0.25
Director
$0 $0 $0
ANAND SHAH MD TRUSTEE 0.25
Director
$0 $0 $0
ADAM SHAPIRO TRUSTEE 0.25
Director
$0 $0 $0
FRANK V SICA TRUSTEE 1.00
Director
$0 $0 $0
JAMES A STERN TRUSTEE 1.00
Director
$0 $0 $0
ROBERT S STOLAR TRUSTEE 1.00
Director
$0 $0 $0
MICHAEL B TARGOFF TRUSTEE 1.00
Director
$0 $0 $0
DIANE TUFT TRUSTEE 1.00
Director
$0 $0 $0
LAUREN S VERONIS TRUSTEE 3.00
Director
$0 $0 $0
RONALD G WEINER TRUSTEE 1.00
Director
$0 $0 $0
JIM WEISS TRUSTEE 4.00
Director
$0 $0 $0
PETER ZHOU TRUSTEE 5.00
Director
$0 $0 $0
ALFRED R MASSIDAS TO 22025 CFO & DIRECTOR OF HUMAN RESOURCES 40.00
Officer
$347,437 $90,161 $437,598
JILL O'DONNELL TORMEY TO 824 CEO & DIRECTOR OF SCIENTIFIC AFFAIRS 40.00
Officer
$539,137 $72,884 $612,021
ALICIA ZHOU PHD START 92024 CEO 40.00
Officer
$0 $0 $0
KATHRYN BEELEY START 22025 CFO 40.00
Officer
$0 $0 $0
DEANNE T MARBACH DIRECTOR OF MAJOR GIFTS 40.00
Key Emp
$155,690 $54,575 $210,265
JAY R CAMPBELL MANAGING DIR OF CRI CLINICAL ACCELERATOR 40.00
Key Emp
$284,937 $83,161 $368,098
LYNNE A RAPINO CHIEF PROGRAM OFFICER 40.00
Key Emp
$287,287 $84,627 $371,914
RUPINDER KAUR CHIEF INFORMATION OFFICER 40.00
Key Emp
$247,910 $64,351 $312,261
SHARON S SLADE CHIEF MARKETING OFFICER 40.00
Key Emp
$273,403 $47,760 $321,163
BRIAN M BREWER CHIEF COMMUNICATIONS OFFICER 40.00
Highest
$148,135 $0 $148,135
MARLA S LAWSON ASSOC DIR OF CORPORATE RELATIONS 40.00
Highest
$136,015 $52,016 $188,031
QING HUA ZHANG CONTROLLER 40.00
Highest
$147,203 $53,996 $201,199
SAMIK K UPADHAYA ASST DIRECTOR, SCIENTIFIC AFFAIRS 40.00
Highest
$145,770 $54,210 $199,980
SHASELL NEGRON ASSOC DIR, COMMUNITY FUNDRAISING 40.00
Highest
$126,437 $32,999 $159,436
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2025 No data No data No data No data
2024 $23,964,638 $32,820,896 $133,734,670 $-8,856,258
2023 $32,295,259 $38,552,663 $138,008,864 $-6,257,404
2022 $33,675,150 $31,314,716 $130,438,312 $2,360,434
2021 $35,987,695 $37,138,977 $146,547,886 $-1,151,282
2020 $37,223,458 $38,496,564 $126,564,196 $-1,273,106
2019 $41,995,692 $34,748,390 $127,608,094 $7,247,302
Explore More Nonprofits
→Top 100 Nonprofits in New York →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare CANCER RESEARCH INSTITUTE INC with other nonprofits in New York and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.